1. What Is an Abdominoplasty Trial?
Abdominoplasty trials are structured research studies that evaluate new techniques, medications, or devices used during or after a tummy tuck (abdominoplasty) procedure. Participants typically undergo standard surgical steps alongside investigational interventions—such as novel analgesic implants or RNA‑based therapies—to assess safety, efficacy, and patient outcomes.
Relatedsearches![]()
2. How Do Abdominoplasty Trials Work?
Most trials follow these components:
1.Screening & Consent: Potential participants undergo medical evaluation and review of inclusion/exclusion criteria before providing informed consent.
2.Surgical Procedure: Standard abdominoplasty is performed by qualified surgeons, with investigational treatments integrated intraoperatively or postoperatively.
3.Intervention Examples:
- Bupivacaine HCl Implant (INL‑001): A sustained‑release analgesic placed at the surgical site to reduce postoperative pain and opioid use
- VX‑548 Oral Analgesic: An experimental non‑opioid pain medication administered within hours of surgery to evaluate acute pain relief
- STP705 siRNA Therapeutic: A small interfering RNA aimed at enhancing fat reduction and scar modulation in adults undergoing tummy tuck
4.Follow‑Up & Assessments: Participants attend scheduled visits for pain scoring, wound healing evaluation, and patient‑reported quality‑of‑life measures. Imaging or laboratory tests may be performed to monitor safety.
3. Benefits of Participating in a Trial
- Access to Novel Therapies: Potential early benefit from the latest analgesic or scar‑management technologies.
- Close Clinical Monitoring: Regular assessments by specialists ensure comprehensive postoperative care.
- Contribution to Medical Knowledge: Findings support improvements in surgical protocols and patient experiences, such as reduced pain or enhanced recovery.
Relatedsearches
4. How to Apply for Abdominoplasty Trials
- Identify Suitable Studies: Search ClinicalTrials.gov for “abdominoplasty” or “tummy tuck trial.”
- Review Eligibility Criteria: Check age limits, health status requirements, and procedural specifications—e.g., postpartum back‑pain study parameters
- Contact Study Coordinators: Reach out via the provided phone number or email on the trial listing to express interest.
- Complete Pre‑Enrollment: Submit medical records, sign informed consent documents, and attend a baseline evaluation visit.
- Schedule Surgery & Intervention: Coordinate operative dates and investigational product administration with the research team.
5. What to Expect After Participation
- Pain and Recovery Metrics: Daily pain diaries and brief surveys (e.g., Visual Analog Scale) track analgesic efficacy.
- Follow‑Up Visits: Typically at 1 week, 1 month, and 3–6 months postoperative for wound checks and satisfaction assessments.
- Adverse Event Monitoring: Any unexpected reactions—such as implant site irritation or medication side effects—are documented and managed promptly.
6. Sample Abdominoplasty Trials
| Trial ID | Intervention | Primary Objective |
|---|---|---|
| NCT04785625 | INL‑001 (bupivacaine HCl) implant | Evaluate postsurgical analgesia safety & efficacy |
| NCT05034952 | VX‑548 oral non‑opioid analgesic | Assess acute postoperative pain reduction |
| Sirnaomics STP705 Phase I | siRNA therapeutic for fat reduction & scar modulation | Determine safety in adults undergoing abdominoplasty |
| NCT03143959 | Standard abdominoplasty in postpartum women | Investigate impact on back pain & urinary incontinence |
7. Conclusion
Abdominoplasty clinical trials integrate innovative analgesic and therapeutic approaches into the standard tummy tuck workflow, focusing on enhanced pain management, accelerated recovery, and optimized cosmetic outcomes. Participation offers access to cutting‑edge treatments under expert supervision, contributing valuable data that may shape future surgical standards.
Data Source Links
- https://endeavorct.com/advancing-abdominoplasty-how-clinical-trials-are-improving-safety-recovery/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8687729/
- https://clinicaltrials.gov/study/NCT03143959
- https://www.sirnaomics.com/en/news-room/press-release/20221107sirnaomics-doses-the-first-patient-in-phase-i-clinical-trial-of-rnai-therapeutic-stp705-in-adults-undergoing-abdominoplasty-for-medical-aesthetics-treatment/
- https://clinicaltrials.gov/study/NCT05034952
- https://clinicaltrials.gov/study/NCT04785625
